Specific binding of estradiol to rat coronary artery smooth muscle cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 58, Issue 1, 1996, Pages 83-88

  Bei, Mian ^a   Lavigne, Mark C ^a   Foegh, Marie L ^a   Ramwell, Peter W ^a   Clarke, Robert ^b  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; ESTRADIOL; ESTROGEN RECEPTOR; PROGESTERONE; TESTOSTERONE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CORONARY ARTERY; ESTROGEN BINDING; NONHUMAN; RAT; SMOOTH MUSCLE FIBER;

EID: 0030130590     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-0760(96)00005-2     Document Type: Article

References (26)

1. 1. Kannel W. B., Hjortland M. C. and McNamara P. M. (1976) Menopause and risk of cardiovascular disease: the Framingham study. Ann. Intern. Med. 85, 452-477.
2. 2. Colditz G. A., Willett W. C., Stampfer M. J., Rosner B., Speizer F. E. and Hennekens C. H. (1987) Menopause and the risk of coronary heart disease in women. N. Engl. J. Med. 316, 1105-1110.
3. 3. Barr D. P., Russ E. M. and Eder H. A. (1952) Influence of estrogens on lipoproteins in atherosclerosis. Trans. Assoc. Am. Physicians 65, 102-113.
4. 4. Bush T. L., Barrett-Connor E., Cowan L. D., Criqui M. H., Wallace R. B., Suchindran C. M., Tyroler H. A. and Rifkind B. M. (1987) Cardiovascular morality and noncontraceptive use of estrogen in women: results of the Lipid Research Clinics Program Follow-up Study. Circulation 75, 1102-1109.
5. 5. Stumpf W. E., Sar M. and Amüller G. (1977) The heart: a target for estradiol. Science 196, 319-321.
6. 3H in the human being. J. Clin. Endocrinol. Metab. 23, 306-310.
7. 7. Karas R. H., Patterson B. L. and Mendelsohn M. E. (1994) Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 89, 1943-1950.
8. 8. Vargas R., Wrobleska B., Rego A., Hatch J. and Ramwell P. W. (1992) Oestradiol inhibits smooth muscle proliferation of pig coronary artery. Br. J. Pharmac. 109, 612-617.
9. 9. Chang W., Nakao L., Orimo H. and Murota S. (1980) Stimulation of prostaglandin cyclooxygenase and prostacyclin synthetase activities by estradiol in rat aortic smooth muscle cells. Biochim. Biophys. Acta 620, 472-482.
10. 10. Beldekas J. C., Smith B., Gerstenfdeld L. C., Sonenschein G. E. and Franzblau C. (1981) Effects of 17ß-estradiol on the synthesis of collagen in cultured bovine aortic smooth muscle cells. Biochemistry 20, 2162-2167.
11. 11. Losordo D. W., Kearney M., Kim E. A., Jekanowski J. and Isner J. M. (1994) Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 89, 1501-1510.
12. 12. Diglio C. A., Grammas P., Giacomelli F. and Wiener L. (1988) Rat heart-derived endothelial and smooth muscle cell cultures: isolation, cloning and characterization. Tissue and Cell 20, 477-496.
13. 13. Soule H. D., Vasquez J., Long A., Albert S. and Brennan M. (1973) A human cell line from a pleural effusion derived from a human breast carcinoma. J. Natl. Cancer Inst. 51, 1409-1416.
14. 14. Clarke R., Brunner N., Katz D., Glanz P., Dickson R. B., Lippman M. E. and Kern R. (1989) The effects of a constitutive production of TGF-α on the growth of MCF-7 human breast cancer cells in vitro and in vivo. Mol. Endocrinol. 3, 372-380.
15. 15. Orimo A., Inoue S., Ikegami A., Hosoi T., Akishita M., Ouchi Y., Muramatsu M. and Orimo H. (1993) Vascular smooth muscle cells as target for estrogen. Biochem. Biophys. Res. Commun. 195, 730-736.
16. 16. Clarke R., Morwood J., van den Berg H. W., Nelson J. and Murphy R.F. (1986) The effect of cytotoxic drugs on estrogen receptor expression and response to tamoxifen in MCF-7 cells. Cancer Res. 46, 6116-6119.
17. 17. van den Berg H. W., Leahey W. J., Lynch M., Clarke R. and Nelson J. (1987) Recombinant human interferon alpha increases oestrogen receptor expression in human breast cancer cells (ZR-75-1) and sensitises them to the anti-proliferative effects of tamoxifen. Br. J. Cancer 55, 255-257.
18. 18. Munson P. J. and Rodbard D. (1980) LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Analyt. Biochem. 107, 220-239.
19. 19. Koike S. and Sakai M. (1987) Molecular cloning and characterization of rat estrogen receptor. Nucl. Acid Res. 15, 2499-2513.
20. 20. Neame R. D. and Richards T. G.: Analysis of experimental data. In Elementary Kinetics of Membrane Carrier Transport. (1972) 41-55.
21. 21. Sagnella G. A. (1994) Estimation of kinetic constants in ion transport studies: regression analysis and Monte-Carlo simulation. Clin. Sci. 87, 371-381.
22. 22. Scatchard G. (1949) The attractions of protein for small molecules and ions. Ann. NY Acad. Sci. 51, 660-672.
23. 23. Klotz I. M. (1983) Ligand-receptor interactions: what we can and cannot learn from binding measurements. Trends Pharmacol. Sci. 4, 253-255.
24. 24. Clarke R., Brünner N., Katzenellenbogen B. S., Thompson E. W., Norman M. J., Koppi C., Paik S., Lippman M. E. and Dickson R. B. (1989) Progression from hormone dependent to hormone independent growth in MCF-7 human breast cancer cells. Proc. Natl. Acad. Sci. U.S.A. 86, 3649-3653.
25. 25. Bürgisser E. (1984) Radioligand-receptor binding studies: what's wrong with the Scatchard analysis?. Trends Pharmacol. Sci. 5, 142-144.
26. 26. Klotz I. M. (1982) Numbers of receptor sites from Scatchard graphs: facts and fantasies. Science 217, 1247-1249.